BioHarvest Sciences (BHST) Competitors $7.58 -0.27 (-3.44%) As of 03:16 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsTrendsBuy This Stock BHST vs. SLDB, PRTC, RGNX, CMPX, TECX, AQST, FULC, KMDA, ERAS, and SNDLShould you be buying BioHarvest Sciences stock or one of its competitors? The main competitors of BioHarvest Sciences include Solid Biosciences (SLDB), PureTech Health (PRTC), REGENXBIO (RGNX), Compass Therapeutics (CMPX), Tectonic Therapeutic (TECX), Aquestive Therapeutics (AQST), Fulcrum Therapeutics (FULC), Kamada (KMDA), Erasca (ERAS), and SNDL (SNDL). These companies are all part of the "pharmaceutical products" industry. BioHarvest Sciences vs. Its Competitors Solid Biosciences PureTech Health REGENXBIO Compass Therapeutics Tectonic Therapeutic Aquestive Therapeutics Fulcrum Therapeutics Kamada Erasca SNDL BioHarvest Sciences (NASDAQ:BHST) and Solid Biosciences (NASDAQ:SLDB) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, earnings, media sentiment, analyst recommendations, institutional ownership, profitability, valuation and risk. Do analysts rate BHST or SLDB? BioHarvest Sciences presently has a consensus price target of $13.67, suggesting a potential upside of 80.30%. Solid Biosciences has a consensus price target of $15.10, suggesting a potential upside of 115.71%. Given Solid Biosciences' stronger consensus rating and higher probable upside, analysts clearly believe Solid Biosciences is more favorable than BioHarvest Sciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score BioHarvest Sciences 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00Solid Biosciences 0 Sell rating(s) 0 Hold rating(s) 10 Buy rating(s) 2 Strong Buy rating(s) 3.17 Which has higher valuation and earnings, BHST or SLDB? BioHarvest Sciences has higher revenue and earnings than Solid Biosciences. BioHarvest Sciences is trading at a lower price-to-earnings ratio than Solid Biosciences, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBioHarvest Sciences$25.19M4.94-$12.91M-$0.50-15.16Solid BiosciencesN/AN/A-$124.70M-$2.99-2.34 Does the media prefer BHST or SLDB? In the previous week, Solid Biosciences had 4 more articles in the media than BioHarvest Sciences. MarketBeat recorded 5 mentions for Solid Biosciences and 1 mentions for BioHarvest Sciences. BioHarvest Sciences' average media sentiment score of 0.96 beat Solid Biosciences' score of 0.75 indicating that BioHarvest Sciences is being referred to more favorably in the media. Company Overall Sentiment BioHarvest Sciences Positive Solid Biosciences Positive Is BHST or SLDB more profitable? Solid Biosciences has a net margin of 0.00% compared to BioHarvest Sciences' net margin of -31.30%. Solid Biosciences' return on equity of -68.15% beat BioHarvest Sciences' return on equity.Company Net Margins Return on Equity Return on Assets BioHarvest Sciences-31.30% -307.04% -33.21% Solid Biosciences N/A -68.15%-55.33% Which has more risk and volatility, BHST or SLDB? BioHarvest Sciences has a beta of 0.65, suggesting that its stock price is 35% less volatile than the S&P 500. Comparatively, Solid Biosciences has a beta of 2.34, suggesting that its stock price is 134% more volatile than the S&P 500. Do insiders and institutionals hold more shares of BHST or SLDB? 81.5% of Solid Biosciences shares are held by institutional investors. 1.9% of Solid Biosciences shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term. SummarySolid Biosciences beats BioHarvest Sciences on 11 of the 16 factors compared between the two stocks. Get BioHarvest Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for BHST and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BHST and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BHST vs. The Competition Export to ExcelMetricBioHarvest SciencesMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$124.46M$3.04B$5.74B$9.51BDividend YieldN/A2.40%4.60%3.99%P/E Ratio-15.1621.1828.1120.03Price / Sales4.94339.43461.37103.88Price / CashN/A43.2336.5559.01Price / Book94.758.368.655.90Net Income-$12.91M-$55.19M$3.25B$258.66M7 Day Performance9.54%5.89%4.21%2.22%1 Month Performance13.98%17.63%10.82%12.76%1 Year PerformanceN/A5.09%34.70%19.36% BioHarvest Sciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BHSTBioHarvest SciencesN/A$7.58-3.4%$13.67+80.3%N/A$124.46M$25.19M-15.16N/ANews CoverageGap DownSLDBSolid Biosciences3.2656 of 5 stars$6.39+10.4%$15.10+136.3%-24.4%$448.81M$8.09M-2.14100High Trading VolumePRTCPureTech Health2.7951 of 5 stars$19.06+3.0%$45.00+136.1%-16.2%$444.47M$4.83M0.00100Positive NewsUpcoming EarningsRGNXREGENXBIO4.1758 of 5 stars$8.16-6.1%$31.63+287.6%-33.1%$435.89M$83.33M-2.62370News CoveragePositive NewsCMPXCompass Therapeutics3.025 of 5 stars$3.00-4.8%$12.67+322.2%+230.9%$435.59M$850K-7.3220Positive NewsTECXTectonic Therapeutic2.6009 of 5 stars$21.91-5.9%$83.60+281.6%+31.1%$434.70MN/A-3.00120Positive NewsAQSTAquestive Therapeutics1.7091 of 5 stars$4.20-3.9%$10.14+141.5%+24.6%$434.06M$57.56M-7.12160FULCFulcrum Therapeutics0.5432 of 5 stars$7.65-3.7%$6.29-17.8%-8.6%$428.60M$80M-109.27100Upcoming EarningsKMDAKamada4.1156 of 5 stars$7.45+0.3%$13.00+74.5%+33.7%$427.26M$160.95M25.69360News CoverageERASErasca2.901 of 5 stars$1.50+0.7%$4.57+204.8%-45.0%$422.10MN/A-2.42120Positive NewsSNDLSNDL1.8885 of 5 stars$1.54-1.3%$4.00+159.7%-30.8%$409.93M$671.81M-5.312,516News CoverageUpcoming EarningsGap Up Related Companies and Tools Related Companies Solid Biosciences Competitors PureTech Health Competitors REGENXBIO Competitors Compass Therapeutics Competitors Tectonic Therapeutic Competitors Aquestive Therapeutics Competitors Fulcrum Therapeutics Competitors Kamada Competitors Erasca Competitors SNDL Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BHST) was last updated on 7/25/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredTreasury Secretary Bessent Is Betting Big on GoldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | SponsoredTurn $1K into $50K with This DeFi GemI've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. Th...Crypto 101 Media | SponsoredHow to Collect Up To $5,917/mo From Trump’s Made In USA BoomHow to Collect Up To $5,917/mo From Trump's Made In USA Boom Thanks to President Trump's America-First poli...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioHarvest Sciences Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BioHarvest Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
